<DOC>
	<DOCNO>NCT00234156</DOCNO>
	<brief_summary>This study evaluate common dietary sugar ( fructose ) raise blood fat ( triglyceride ) . We determine whether production fat fructose high dialysis patient compare healthy volunteer . Dialysis patient high level hormone-like substance call cytokine may increase blood fat . The result help set good guideline diet general population patient kidney disease high risk heart attack stroke . There one two outpatient screen visit ( ) one-week ( 6 night ) stay Rockefeller University Hospital .</brief_summary>
	<brief_title>The Effect Fructose Blood Fats Dialysis Patients Healthy Volunteers</brief_title>
	<detailed_description>Fifteen hemodialysis patient 15 healthy volunteer study . Outpatient screen visit ( ) : consent , fast blood urine analysis , physical exam , EKG 2-hour oral glucose tolerance test screen diabetes . Inpatient admission : - Standardized diet follow guideline hemodialysis patient healthy volunteer maintain stable weight . - Blood urine sampling . The total amount blood drawn le 1 cup . - To measure production fat fructose , trace amount non-radioactive label precursor fat ( 13C-acetate ) infuse venous catheter 22 hour . At end infusion , sweet drink ( fructose 1 ounce water ) give orally every half hour 6 hour . â€¢ Two small sample fat take right skin obtain injection small amount numb medicine abdominal gluteal region . Dialysis patient receive usual dialysis The Rogosin Institute Manhattan , Brooklyn Queens Dialysis Units .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>1 . Male female , 1875 year age . 2 . Chronic renal failure hemodialysis 3x/week least 6 month adequate dialysis judge nephrologist study investigator . 3 . Fasting TG &lt; 600 mg/dl , LDL cholesterol &lt; 190 mg/dl ( lipidlowering medication ) 4 . Willing able change Renagel , noncalcemic phosphate binder ( poly [ allylamine hydrochloride ] ) LDLlowering effect , amount another phosphate binder 1 month prior screen visit completion study . 5 . Willing able temporarily stop Sensipar ( cinacalcet ) 1 week study admission completion study ( total ~2 week ) . 6 . Willing able stop ASA ( except low dose ASA patient vascular disease ) , NSAID , fish oil , psyllium , nonprescribed vitamins/supplements 1 week prior study completion study . 7 . Willing able sign inform consent . 8 . Willing refrain participation investigational drug study duration study . 1 . Diabetes ( fast blood sugar &gt; 126 twice abnormal 2 hour OGTT ) 2 . Unstable clinical condition , include acute febrile illness within 1 month admission 3 . Chronic infection , include hepatitis HIV infection 4 . Gastrointestinal disease result significant GI dysfunction malabsorption 5 . Lipidlowering medication 6 . Mean systolic blood pressure &gt; 180 diastolic pressure &gt; 110 take immediately 6 dialysis treatment 2 week screen visit 7/15/2008 Form version 6/13/2005 # LHU04710407 Page 8of 16f 7 . BMI &gt; 35 ( markedly obese ) 8 . Hemoglobin &lt; 10.0 9 . Prednisone , estrogen/progesterone , steroid , Synthroid , endocrine disease 10 . Coumadin INR &gt; 1.5 11 . Cigarette smoke &gt; 1/2 pack/day 12 . Abuse ethanol ( great 2 drinks/day ) illicit drug 13 . If female , pregnant breast feed 14 . Participation study investigational drug 30 day precede start screen period 15 . Have condition , opinion investigator , prohibit participation study Healthy Controls : Inclusion Criteria 1 . Male female , 1875 year age 2 . LDL &lt; 160 mg/dl , HDLC &gt; 30 mg/dl , TG &lt; 250 mg/dl 3 . Willing able stop ASA , NSAID , fish oil , psyllium , vitamins/supplements 1 week prior study completion study 4 . Willing able sign inform consent 5 . Willing refrain participation investigational drug study duration study Exclusion Criteria 1 . Systemic illness , include diabetes ( FBS &gt; 126 twice abnormal OGTT ) , cardiovascular disease , hepatitis , endocrine disease , HIV infection . 2 . Prescription medication , include contraceptive . 3 . Acute febrile illness within 1 month admission . 4 . BMI &gt; 35 ( markedly obese ) &gt; 10 % maximum weight . 5 . Weight change &gt; 10 % usual weight previous 6 month . 6 . Blood pressure &gt; 140/90 . 7 . HB &lt; 11 female , &lt; 12 male . 8 . CRP &gt; 5.0 2 occasion . 7/15/2008 Form version 6/13/2005 # LHU04710407 Page 9of 16f 9 . Abuse ethanol ( great 2 drinks/day ) illicit drug . 10 . Cigarette smoke &gt; 1/2 pack/day . 11 . Unusual diet extreme physical activity ( e.g . marathon runner ) . 12 . If female , pregnant breast feeding . 13 . Participation study investigational drug 30 day precede start screen period . 14 . Have condition , opinion investigator , prohibit participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Fructose</keyword>
	<keyword>Lipogenesis</keyword>
	<keyword>Triglycerides</keyword>
	<keyword>Dialysis</keyword>
</DOC>